Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by B-cell lymphoma 2 Inhibitors Revenue 1.4 Market Analysis by Type 1.4.1 Global B-cell lymphoma 2 Inhibitors Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Combination Therapy 1.4.3 Monotherapy 1.5 Market by Application 1.5.1 Global B-cell lymphoma 2 Inhibitors Market Share by Application: 2020 VS 2026 1.5.2 Chronic Lymphocytic Leukemia 1.5.3 Small Lymphocytic Lymphoma 1.5.4 Cute Myeloid Leukemia 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 B-cell lymphoma 2 Inhibitors Market Perspective (2015-2026) 2.2 B-cell lymphoma 2 Inhibitors Growth Trends by Regions 2.2.1 B-cell lymphoma 2 Inhibitors Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 B-cell lymphoma 2 Inhibitors Historic Market Share by Regions (2015-2020) 2.2.3 B-cell lymphoma 2 Inhibitors Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 B-cell lymphoma 2 Inhibitors Market Growth Strategy 2.3.6 Primary Interviews with Key B-cell lymphoma 2 Inhibitors Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top B-cell lymphoma 2 Inhibitors Players by Market Size 3.1.1 Global Top B-cell lymphoma 2 Inhibitors Players by Revenue (2015-2020) 3.1.2 Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Players (2015-2020) 3.1.3 Global B-cell lymphoma 2 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global B-cell lymphoma 2 Inhibitors Market Concentration Ratio 3.2.1 Global B-cell lymphoma 2 Inhibitors Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by B-cell lymphoma 2 Inhibitors Revenue in 2019 3.3 B-cell lymphoma 2 Inhibitors Key Players Head office and Area Served 3.4 Key Players B-cell lymphoma 2 Inhibitors Product Solution and Service 3.5 Date of Enter into B-cell lymphoma 2 Inhibitors Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global B-cell lymphoma 2 Inhibitors Historic Market Size by Type (2015-2020) 4.2 Global B-cell lymphoma 2 Inhibitors Forecasted Market Size by Type (2021-2026) 5 B-cell lymphoma 2 Inhibitors Breakdown Data by Application (2015-2026) 5.1 Global B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) 5.2 Global B-cell lymphoma 2 Inhibitors Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America B-cell lymphoma 2 Inhibitors Market Size (2015-2020) 6.2 B-cell lymphoma 2 Inhibitors Key Players in North America (2019-2020) 6.3 North America B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) 6.4 North America B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) 7 Europe 7.1 Europe B-cell lymphoma 2 Inhibitors Market Size (2015-2020) 7.2 B-cell lymphoma 2 Inhibitors Key Players in Europe (2019-2020) 7.3 Europe B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) 7.4 Europe B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) 8 China 8.1 China B-cell lymphoma 2 Inhibitors Market Size (2015-2020) 8.2 B-cell lymphoma 2 Inhibitors Key Players in China (2019-2020) 8.3 China B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) 8.4 China B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) 9 Japan 9.1 Japan B-cell lymphoma 2 Inhibitors Market Size (2015-2020) 9.2 B-cell lymphoma 2 Inhibitors Key Players in Japan (2019-2020) 9.3 Japan B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) 9.4 Japan B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia B-cell lymphoma 2 Inhibitors Market Size (2015-2020) 10.2 B-cell lymphoma 2 Inhibitors Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) 10.4 Southeast Asia B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) 11 India 11.1 India B-cell lymphoma 2 Inhibitors Market Size (2015-2020) 11.2 B-cell lymphoma 2 Inhibitors Key Players in India (2019-2020) 11.3 India B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) 11.4 India B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America B-cell lymphoma 2 Inhibitors Market Size (2015-2020) 12.2 B-cell lymphoma 2 Inhibitors Key Players in Central & South America (2019-2020) 12.3 Central & South America B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) 12.4 Central & South America B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) 13Key Players Profiles 13.1 AbbVie Inc. 13.1.1 AbbVie Inc. Company Details 13.1.2 AbbVie Inc. Business Overview and Its Total Revenue 13.1.3 AbbVie Inc. B-cell lymphoma 2 Inhibitors Introduction 13.1.4 AbbVie Inc. Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020)) 13.1.5 AbbVie Inc. Recent Development 13.2 F. Hoffmann-La Roche Ltd. 13.2.1 F. Hoffmann-La Roche Ltd. Company Details 13.2.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue 13.2.3 F. Hoffmann-La Roche Ltd. B-cell lymphoma 2 Inhibitors Introduction 13.2.4 F. Hoffmann-La Roche Ltd. Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020) 13.2.5 F. Hoffmann-La Roche Ltd. Recent Development 13.3 Santa Cruz Biotechnology 13.3.1 Santa Cruz Biotechnology Company Details 13.3.2 Santa Cruz Biotechnology Business Overview and Its Total Revenue 13.3.3 Santa Cruz Biotechnology B-cell lymphoma 2 Inhibitors Introduction 13.3.4 Santa Cruz Biotechnology Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020) 13.3.5 Santa Cruz Biotechnology Recent Development 13.4 Tocris 13.4.1 Tocris Company Details 13.4.2 Tocris Business Overview and Its Total Revenue 13.4.3 Tocris B-cell lymphoma 2 Inhibitors Introduction 13.4.4 Tocris Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020) 13.4.5 Tocris Recent Development 13.5 Biovision 13.5.1 Biovision Company Details 13.5.2 Biovision Business Overview and Its Total Revenue 13.5.3 Biovision B-cell lymphoma 2 Inhibitors Introduction 13.5.4 Biovision Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020) 13.5.5 Biovision Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. B-cell lymphoma 2 Inhibitors Key Market Segments Table 2. Key Players Covered: Ranking by B-cell lymphoma 2 Inhibitors Revenue Table 3. Ranking of Global Top B-cell lymphoma 2 Inhibitors Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global B-cell lymphoma 2 Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Combination Therapy Table 6. Key Players of Monotherapy Table 7. Global B-cell lymphoma 2 Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global B-cell lymphoma 2 Inhibitors Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global B-cell lymphoma 2 Inhibitors Market Size by Regions (2015-2020) (US$ Million) Table 10. Global B-cell lymphoma 2 Inhibitors Market Share by Regions (2015-2020) Table 11. Global B-cell lymphoma 2 Inhibitors Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global B-cell lymphoma 2 Inhibitors Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. B-cell lymphoma 2 Inhibitors Market Growth Strategy Table 17. Main Points Interviewed from Key B-cell lymphoma 2 Inhibitors Players Table 18. Global B-cell lymphoma 2 Inhibitors Revenue by Players (2015-2020) (Million US$) Table 19. Global B-cell lymphoma 2 Inhibitors Market Share by Players (2015-2020) Table 20. Global Top B-cell lymphoma 2 Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-cell lymphoma 2 Inhibitors as of 2019) Table 21. Global B-cell lymphoma 2 Inhibitors by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players B-cell lymphoma 2 Inhibitors Product Solution and Service Table 24. Date of Enter into B-cell lymphoma 2 Inhibitors Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) (Million US$) Table 27. Global B-cell lymphoma 2 Inhibitors Market Size Share by Type (2015-2020) Table 28. Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Type (2021-2026) Table 29. Global B-cell lymphoma 2 Inhibitors Market Size Share by Application (2015-2020) Table 30. Global B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) (Million US$) Table 31. Global B-cell lymphoma 2 Inhibitors Market Size Share by Application (2021-2026) Table 32. North America Key Players B-cell lymphoma 2 Inhibitors Revenue (2019-2020) (Million US$) Table 33. North America Key Players B-cell lymphoma 2 Inhibitors Market Share (2019-2020) Table 34. North America B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) (Million US$) Table 35. North America B-cell lymphoma 2 Inhibitors Market Share by Type (2015-2020) Table 36. North America B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) (Million US$) Table 37. North America B-cell lymphoma 2 Inhibitors Market Share by Application (2015-2020) Table 38. Europe Key Players B-cell lymphoma 2 Inhibitors Revenue (2019-2020) (Million US$) Table 39. Europe Key Players B-cell lymphoma 2 Inhibitors Market Share (2019-2020) Table 40. Europe B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) (Million US$) Table 41. Europe B-cell lymphoma 2 Inhibitors Market Share by Type (2015-2020) Table 42. Europe B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) (Million US$) Table 43. Europe B-cell lymphoma 2 Inhibitors Market Share by Application (2015-2020) Table 44. China Key Players B-cell lymphoma 2 Inhibitors Revenue (2019-2020) (Million US$) Table 45. China Key Players B-cell lymphoma 2 Inhibitors Market Share (2019-2020) Table 46. China B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) (Million US$) Table 47. China B-cell lymphoma 2 Inhibitors Market Share by Type (2015-2020) Table 48. China B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) (Million US$) Table 49. China B-cell lymphoma 2 Inhibitors Market Share by Application (2015-2020) Table 50. Japan Key Players B-cell lymphoma 2 Inhibitors Revenue (2019-2020) (Million US$) Table 51. Japan Key Players B-cell lymphoma 2 Inhibitors Market Share (2019-2020) Table 52. Japan B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) (Million US$) Table 53. Japan B-cell lymphoma 2 Inhibitors Market Share by Type (2015-2020) Table 54. Japan B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) (Million US$) Table 55. Japan B-cell lymphoma 2 Inhibitors Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players B-cell lymphoma 2 Inhibitors Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players B-cell lymphoma 2 Inhibitors Market Share (2019-2020) Table 58. Southeast Asia B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia B-cell lymphoma 2 Inhibitors Market Share by Type (2015-2020) Table 60. Southeast Asia B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia B-cell lymphoma 2 Inhibitors Market Share by Application (2015-2020) Table 62. India Key Players B-cell lymphoma 2 Inhibitors Revenue (2019-2020) (Million US$) Table 63. India Key Players B-cell lymphoma 2 Inhibitors Market Share (2019-2020) Table 64. India B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) (Million US$) Table 65. India B-cell lymphoma 2 Inhibitors Market Share by Type (2015-2020) Table 66. India B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) (Million US$) Table 67. India B-cell lymphoma 2 Inhibitors Market Share by Application (2015-2020) Table 68. Central & South America Key Players B-cell lymphoma 2 Inhibitors Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players B-cell lymphoma 2 Inhibitors Market Share (2019-2020) Table 70. Central & South America B-cell lymphoma 2 Inhibitors Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America B-cell lymphoma 2 Inhibitors Market Share by Type (2015-2020) Table 72. Central & South America B-cell lymphoma 2 Inhibitors Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America B-cell lymphoma 2 Inhibitors Market Share by Application (2015-2020) Table 74. AbbVie Inc. Company Details Table 75. AbbVie Inc. Business Overview Table 76. AbbVie Inc. Product Table 77. AbbVie Inc. Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020) (Million US$) Table 78. AbbVie Inc. Recent Development Table 79. F. Hoffmann-La Roche Ltd. Company Details Table 80. F. Hoffmann-La Roche Ltd. Business Overview Table 81. F. Hoffmann-La Roche Ltd. Product Table 82. F. Hoffmann-La Roche Ltd. Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020) (Million US$) Table 83. F. Hoffmann-La Roche Ltd. Recent Development Table 84. Santa Cruz Biotechnology Company Details Table 85. Santa Cruz Biotechnology Business Overview Table 86. Santa Cruz Biotechnology Product Table 87. Santa Cruz Biotechnology Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020) (Million US$) Table 88. Santa Cruz Biotechnology Recent Development Table 89. Tocris Company Details Table 90. Tocris Business Overview Table 91. Tocris Product Table 92. Tocris Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020) (Million US$) Table 93. Tocris Recent Development Table 94. Biovision Company Details Table 95. Biovision Business Overview Table 96. Biovision Product Table 97. Biovision Revenue in B-cell lymphoma 2 Inhibitors Business (2015-2020) (Million US$) Table 98. Biovision Recent Development Table 99. Research Programs/Design for This Report Table 100. Key Data Information from Secondary Sources Table 101. Key Data Information from Primary Sources List of Figures Figure 1. Global B-cell lymphoma 2 Inhibitors Market Share by Type: 2020 VS 2026 Figure 2. Combination Therapy Features Figure 3. Monotherapy Features Figure 4. Global B-cell lymphoma 2 Inhibitors Market Share by Application: 2020 VS 2026 Figure 5. Chronic Lymphocytic Leukemia Case Studies Figure 6. Small Lymphocytic Lymphoma Case Studies Figure 7. Cute Myeloid Leukemia Case Studies Figure 8. B-cell lymphoma 2 Inhibitors Report Years Considered Figure 9. Global B-cell lymphoma 2 Inhibitors Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global B-cell lymphoma 2 Inhibitors Market Share by Regions: 2020 VS 2026 Figure 11. Global B-cell lymphoma 2 Inhibitors Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global B-cell lymphoma 2 Inhibitors Market Share by Players in 2019 Figure 14. Global Top B-cell lymphoma 2 Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-cell lymphoma 2 Inhibitors as of 2019 Figure 15. The Top 10 and 5 Players Market Share by B-cell lymphoma 2 Inhibitors Revenue in 2019 Figure 16. North America B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2015-2020) (Million US$) Figure 23. AbbVie Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. AbbVie Inc. Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2015-2020) Figure 25. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2015-2020) Figure 27. Santa Cruz Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Santa Cruz Biotechnology Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2015-2020) Figure 29. Tocris Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Tocris Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2015-2020) Figure 31. Biovision Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Biovision Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2015-2020) Figure 33. Bottom-up and Top-down Approaches for This Report Figure 34. Data Triangulation Figure 35. Key Executives Interviewed

AbbVie Inc. F. Hoffmann-La Roche Ltd. Santa Cruz Biotechnology Tocris Biovision